Literature DB >> 2723061

Production of GAWK (chromogranin-B 420-493)-like immunoreactivity by endocrine tumors and its possible diagnostic value.

K Sekiya1, M A Ghatei, M J Salahuddin, A E Bishop, Q A Hamid, H Ibayashi, J M Polak, S R Bloom.   

Abstract

GAWK (chromogranin-B 420-493) is a 74 amino acid peptide recently isolated from human pituitaries. Using two different antibodies (directed against GAWK [1-17] and [20-38] fragments) GAWK-LI was measured in tumors from 194 patients and in the plasma of 434 patients by RIA. The highest tissue concentrations of GAWK-LI were found in pheochromocytoma (GAWK [1-17]-LI, 18,173 +/- 3,915; GAWK [20-38]-LI, 17,852 +/- 2,763 [mean +/- SEM] pmol/g wet wt tissue; n = 9), which were at least ten times higher than any other tumors producing GAWK-LI. High concentrations of GAWK-LI were also found in other types of endocrine tumors including carcinoid, medullary carcinoma of thyroid, pancreatic, and ACTH-producing lung tumors. On the other hand, low concentrations of GAWK-LI were found in nonendocrine tumors. Plasma concentrations of GAWK-LI were found to be elevated in patients with endocrine tumor, but more so in those with pancreatic tumors than with pheochromocytomas. Plasma concentrations returned to normal after successful tumor removal. Chromatographic profiles of GAWK-LI in extracts of pheochromocytomas and normal adrenals showed high molecular weight peaks that were absent in the extracts of other endocrine tumors and normal pancreas, suggesting differential tissue-specific processing. Thus GAWK-LI is produced by a variety of endocrine tumors and may serve as a plasma tumor marker, especially in patients with pancreatic endocrine tumors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2723061      PMCID: PMC303903          DOI: 10.1172/JCI114089

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  28 in total

1.  Chromogranins and neuroendocrine secretion.

Authors:  R H Angeletti
Journal:  Lab Invest       Date:  1986-10       Impact factor: 5.662

2.  Chromogranin: a newly recognized marker for endocrine cells of the human gastrointestinal tract.

Authors:  P Facer; A E Bishop; R V Lloyd; B S Wilson; R J Hennessy; J M Polak
Journal:  Gastroenterology       Date:  1985-12       Impact factor: 22.682

3.  Immunological characterization of secretory proteins of chromaffin granules: chromogranins A, chromogranins B, and enkephalin-containing peptides.

Authors:  R Fischer-Colbrie; I Frischenschlager
Journal:  J Neurochem       Date:  1985-06       Impact factor: 5.372

4.  Immunohistochemical localization of chromogranin in human hypophyses and pituitary adenomas.

Authors:  R V Lloyd; B S Wilson; K Kovacs; N Ryan
Journal:  Arch Pathol Lab Med       Date:  1985-06       Impact factor: 5.534

5.  Chromogranin B (secretogranin I), a putative precursor of two novel pituitary peptides through processing at paired basic residues.

Authors:  S Benjannet; R Leduc; N Adrouche; J P Falgueyret; M Marcinkiewicz; N G Seidah; M Mbikay; C Lazure; M Chretien
Journal:  FEBS Lett       Date:  1987-11-16       Impact factor: 4.124

6.  Distribution of chromogranin and S100 protein in normal and abnormal adrenal medullary tissues.

Authors:  R V Lloyd; M Blaivas; B S Wilson
Journal:  Arch Pathol Lab Med       Date:  1985-07       Impact factor: 5.534

7.  Chromogranin: widespread immunoreactivity in polypeptide hormone producing tissues and in serum.

Authors:  D T O'Connor
Journal:  Regul Pept       Date:  1983-07

8.  Improved section adhesion for immunocytochemistry using high molecular weight polymers of L-lysine as a slide coating.

Authors:  W M Huang; S J Gibson; P Facer; J Gu; J M Polak
Journal:  Histochemistry       Date:  1983

9.  Isolation of human pancreastatin fragment containing the active sequence from a glucagonoma.

Authors:  K Sekiya; M A Ghatei; N Minamino; D Bretherton-Watt; H Matsuo; S R Bloom
Journal:  FEBS Lett       Date:  1988-02-08       Impact factor: 4.124

10.  Immunoreactive human chromogranin A in diverse polypeptide hormone producing human tumors and normal endocrine tissues.

Authors:  D T O'Connor; D Burton; L J Deftos
Journal:  J Clin Endocrinol Metab       Date:  1983-11       Impact factor: 5.958

View more
  7 in total

Review 1.  Gut endocrine and neural peptides.

Authors:  Anne E Bishop; Julia M Polak
Journal:  Endocr Pathol       Date:  1990-03       Impact factor: 3.943

2.  Chromogranin A and B in parathyroid tissue of cases of primary hyperparathyroidism: an immunohistochemical study.

Authors:  K W Schmid; A Hittmair; D Ladurner; P Sandbichler; R Gasser; M Tötsch
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991

3.  Elevated cocaine- and amphetamine-regulated transcript immunoreactivity in the circulation of patients with neuroendocrine malignancy.

Authors:  Paul Bech; Virginia Winstanley; Kevin G Murphy; Amir H Sam; Karim Meeran; Mohammad A Ghatei; Stephen R Bloom
Journal:  J Clin Endocrinol Metab       Date:  2008-01-22       Impact factor: 5.958

4.  Mass spectrometry identification of granins and other proteins secreted by neuroblastoma cells.

Authors:  Wojciech Rozek; Malgorzata Kwasnik; Janusz Debski; Jan F Zmudzinski
Journal:  Tumour Biol       Date:  2013-03-22

5.  The association of a panel of biomarkers with the presence and severity of carcinoid heart disease: a cross-sectional study.

Authors:  Rebecca Dobson; Malcolm I Burgess; Melissa Banks; D Mark Pritchard; Jiten Vora; Juan W Valle; Christopher Wong; Carrie Chadwick; Keith George; Brian Keevil; Joanne Adaway; Joy E S Ardill; Alan Anthoney; Uschi Hofmann; Graeme J Poston; Daniel J Cuthbertson
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

6.  Characterization and plasma measurement of the WE-14 peptide in patients with pheochromocytoma.

Authors:  Johann Guillemot; Marlène Guérin; Erwan Thouënnon; Maité Montéro-Hadjadje; Jérôme Leprince; Hervé Lefebvre; Marc Klein; Mihaela Muresan; Youssef Anouar; Laurent Yon
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

Review 7.  The chromogranins A and B: the first 25 years and future perspectives.

Authors:  H Winkler; R Fischer-Colbrie
Journal:  Neuroscience       Date:  1992-08       Impact factor: 3.590

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.